EXPRESSION OF TISSUE FACTOR BY MELANOMA-CELLS PROMOTES EFFICIENT HEMATOGENOUS METASTASIS

被引:352
作者
MUELLER, BM
REISFELD, RA
EDGINGTON, TS
RUF, W
机构
[1] Department of Immunology, Scripps Research Institute, La Jolla
关键词
D O I
10.1073/pnas.89.24.11832
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Metastasis is a multistep process which requires highly adapted interactions of tumor cells with host target organs. Compared with nonmetastatic cells, metastatic human melanoma cells express 1000-fold higher levels of tissue factor (TF), the major cellular initiator of the plasma coagulation protease cascades. To explore whether TF may contribute to metastatic tumor dissemination, we analyzed the effect of specific inhibition of TF function on human melanoma metastasis in severe combined immunodeficient (SCID) nice. Using species-specific antibodies to TF, we demonstrate that initial adherence is insufficient for successful tumor cell implantation in a target organ. Rapid arrest of human tumor cells in the lungs of mice was not diminished by inhibition of TF. However, inhibition of TF receptor function and consequent reduction in local protease generation abolished prolonged adherence of tumor cells, resulting in significantly reduced numbers of tumor cells retained in the vasculature of the lungs. The growth of pulmonary metastases was also significantly inhibited by a blocking anti-TF monoclonal antibody and Fab fragments thereof, whereas a noninhibitory antibody lacked antimetastatic effects. Cell surface expression of functional TF thus contributes to melanoma progression by allowing metastatic cells to provide requisite signals for prolonged adhesive interactions and/or transmigration of tumor cells across the endothelium, resulting in successful metastatic tumor implantation.
引用
收藏
页码:11832 / 11836
页数:5
相关论文
共 51 条
[1]  
AKSLEN LA, 1988, INVAS METAST, V8, P193
[2]   GRANULE MEMBRANE PROTEIN-140 (GMP140) BINDS TO CARCINOMAS AND CARCINOMA-DERIVED CELL-LINES [J].
ARUFFO, A ;
DIETSCH, MT ;
WAN, H ;
HELLSTROM, KE ;
HELLSTROM, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2292-2296
[3]   TISSUE FACTOR GENE-EXPRESSION IN ACUTE MYELOBLASTIC-LEUKEMIA [J].
BAUER, KA ;
CONWAY, EM ;
BACH, R ;
KONIGSBERG, WH ;
GRIFFIN, JD ;
DEMETRI, G .
THROMBOSIS RESEARCH, 1989, 56 (03) :425-430
[4]  
BURROWS FJ, 1991, CANCER RES, V51, P4768
[5]   LEUKOCYTE-ENDOTHELIAL CELL RECOGNITION - 3 (OR MORE) STEPS TO SPECIFICITY AND DIVERSITY [J].
BUTCHER, EC .
CELL, 1991, 67 (06) :1033-1036
[6]   INVITRO AND INVIVO CONSEQUENCES OF VLA-2 EXPRESSION ON RHABDOMYOSARCOMA CELLS [J].
CHAN, BMC ;
MATSUURA, N ;
TAKADA, Y ;
ZETTER, BR ;
HEMLER, ME .
SCIENCE, 1991, 251 (5001) :1600-1602
[7]   TUMOR PROGRESSION AND THE NATURE OF CANCER [J].
CLARK, WH .
BRITISH JOURNAL OF CANCER, 1991, 64 (04) :631-644
[8]   VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION [J].
CLAUSS, M ;
GERLACH, M ;
GERLACH, H ;
BRETT, J ;
WANG, F ;
FAMILLETTI, PC ;
PAN, YCE ;
OLANDER, JV ;
CONNOLLY, DT ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1535-1545
[9]   ENHANCED TUMORIGENICITY, MELANOGENESIS, AND METASTASES OF A HUMAN-MALIGNANT MELANOMA AFTER SUBDERMAL IMPLANTATION IN NUDE-MICE [J].
CORNIL, I ;
MAN, S ;
FERNANDEZ, B ;
KERBEL, RS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (12) :938-944
[10]   CHARACTERIZATION OF A FUNCTIONAL THROMBIN RECEPTOR - ISSUES AND OPPORTUNITIES [J].
COUGHLIN, SR ;
VU, TKH ;
HUNG, DT ;
WHEATON, VI .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) :351-355